检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Bimekizumab efficacy and safety through three years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE randomized controlled trial and the BE BRIGHT open-label extension

Diamant Thaçi,Ron Vender,Menno De Rie,Curdin Conrad,Jennifer Soung,Bruce Strober,Maggie Wang,Nancy Cross,Delphine Deherder,Natalie Nunez Gomez,Alice B Gottlieb

SKIN The Journal of Cutaneous Medicine（2022）

引用 1|浏览1
暂无评分
摘要
N/A
更多
查看译文
关键词
severe plaque psoriasis,long-term,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要